Skip to main content

Table 2 Univariate and multivariate Cox regression analyses of overall survival

From: ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway

Clinical characteristics

Univariable analysis

Multivariabl analysis

HR (95%)

P value

HR (95%)

P value

Age, years (<  50 vs. ≥ 50)

0.820 (0.441–1.526)

0.532

1.143 (0.592–2.207)

0.691

Gender (Female vs. male)

2.253 (0.885–5.737)

0.089

2.970 (1.141–7.730)

0.026

Liver cirrhosis (No vs. Yes)

0.577 (0.244–1.368)

0.212

0.787 (0.311–1.991)

0.613

Tumor size, cm (<  5 vs. ≥ 5)

0.365 (0.176–0.758)

0.007

0.449 (0.211–0.953)

0.037

Tumor number (Single vs. Multiple)

1.436 (0.512–4.025)

0.492

2.242 (0.725–6.930)

0.161

Tumor encapsulation (Complete vs. None)

1.245 (0.662–2.341)

0.496

0.945 (0.481–1.860)

0.871

Pathological stage (I-II vs. III-IV)

2.134 (1.173–3.881)

0.013

1.729 (0.860–3.478)

0.124

ERCC6L (high vs. low)

0.463 (0.234–0.917)

0.027

0.437 (0.195–0.982)

0.045